Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Outset Medical: Profitability Path Brightens

TheMotleyFool 
0 0 20.02.25
Outset Medical: Profitability Path Brightens
 

Outset Medical (NASDAQ:OM), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and bottom lines. Fourth-quarter revenue of $29.5 million exceeded the forecasted $28 million, indicating resilience in revenue growth despite market hurdles. The adjusted EPS loss of $0.37 was better than the projected loss of $0.44.

Overall, the company reported a quarter marked by enhanced operational efficiency and improved financial metrics.

Source: Outset Medical. Note: Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year.

Continue reading


Source Fool.com

Electro Power Systems S.A. Stock

Show more
Like: 0
OM
Share

Comments

Not a member yet? Sign up for free!